Chargement en cours...
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification
BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...
Enregistré dans:
| Publié dans: | J Neurointerv Surg |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629931/ https://ncbi.nlm.nih.gov/pubmed/27799376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2016-012612 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|